This retrospective study aimed to determine the effectiveness of sacral neuromodulation (SNM) on neurogenic lower urinary tract dysfunction (NLUTD) and analyze the predictive factors.
From January 2012 to January 2020, 152 subjects with NLUTD from four medical centers in China received SNM test stimulation.